Research article - (2004)03, 49 - 54
Physical Activity Alters Urinary Albumin/ Creatinine Ratio in Type 1 Diabetic Patient
Ercan Tuncel, Erdinc Erturk, Canan Ersoy, Sinem Kiyici, Cevdet Duran, Nesrin Kuru, Sazi Imamoglu
Uludag University School of Medicine, Department of Endocrinology, Bursa, Turkey

Erdinc Erturk
✉ Uludag University School of Medicine, Department of Endocrinology, Bursa 16059 Turkey
Email: ererturk@uludag.edu.tr
Received: 09-11-2003 -- Accepted: 11-12-2003
Published (online): 01-03-2004

ABSTRACT

While the best way to identify microalbuminuria is to determine albumin excretion rate (AER) in a 24 h urine sample. Published data have shown that calculation of an albumin/creatinine ratio (ACR) in a spot urine sample has reasonable rate of sensitivity and specificity. We aimed to evaluate the effect of daily exercise on ACR and estimate the best time for the examination of the ACR in a spot urine sample. Sixteen eligible patients with Type 1 diabetes mellitus were asked to perform varying degree of exercise periods. Urinary albumin and creatinine excretion rates during each period were determined. ACR and AER of timed urinary samples were compared with the 24 hour urinary AER. We found significant correlations between timed and 24 hour urinary AER. According to diagnostic performance tests, ACR and AER of timed urine samples were both found to be significantly more sensitive during resting period when compared with mild or moderate active periods. It is concluded that ACR and AER of a timed urine sample are sensitive and specific methods for determining microalbuminuria, while overnight resting samples give the impression of being more diagnostic.

Key words: Microalbuminuria, albumin/creatinine ratio, type 1 diabetes mellitus, exercise, nephropathy

Key Points
  • Timed urine samples can predict microalbuminuria but because of the erroneous urine collections, microalbuminuria measurement should be calculated with creatiniuria measurement.
  • With increasing physical activity during urine collection diagnostic performances of the cut-off values go downhill.
  • For detecting microalbuminuria best results are reached with the early-morning urine samples.
INTRODUCTION

The presence of microalbuminuria (30-299 mg·dL-1 or 20-199 µg·min-1) predicts deterioration of renal disease to overt diabetic nephropathy in diabetic patients (Viberti et al., 1982; Krolewski et al., 1985) and elevated risk of cardiovascular disease in diabetic and non-diabetic individuals (Agewall et al., 1997; Yudkin et al., 1988). The early detection of microalbuminuria has been widely advocated as means of diagnosing and treating early renal involvement in diabetes (MCSG, 1993; Bennett et al., 1995). Measurement of albumin excretion rate (AER) in a 24 hour urine sample is the most reliable way for the detection of microalbuminuria (Mogensen et al., 1995; Tobe et al., 2002). Quantitative or qualitative assessment of AER in a spot urine sample gives high rate of false negative and positive results due to water intake. Published data have shown that the calculation of albumin/ creatinine ratio (ACR) in a spot urine sample exhibits a higher sensitivity and specificity in the detection of microalbuminuria (Gatling et al., 1985; Eshoj et al., 1987; Khawali et al., 2002). This method has certain advantages, as it is easily available, non-expensive and reproducible, but several conditions such as posture, exercise, ketosis may lead to inappropriate increase of the urinary albumin excretion (Abbott et al., 1994; Gomes and Goncalves, 2001).

The value of ACR is controversially discussed in the literature. Whereas some authors recommended ACR as the method of choice for the detection of microalbuminuria (Shield et al., 1995; Newman et al., 2000; Tobe et al., 2002), other published data demonstrated only a limited value of ACR as a screening method of microalbuminuria (Marshall, 1991; Derhasching et al., 2002). The circadian rhythm of proteinuria, blood glucose control, dietary protein content and physical activity are the main contributors of the inaccuracy of ACR (Rowe et al., 1984; Jefferson et al., 1985). In this study we aimed to evaluate the effect of daily exercise on ACR and estimate the best time and best intensity of the physical activity for the examination of the ACR in a spot urine sample to detect microalbuminuria in patients with Type 1 diabetes mellitus.

METHODS
Patient selection

Patients with Type 1 diabetes mellitus without hypertension, macroalbuminuria or renal insufficiency. Insulin treated diabetic patients with the onset of diabetes before the age of 25, with duration of diabetes more than 3 years and with no clinical evidence of cardiovascular, peripheral vascular or renal disease were screened for AER. Patients with the history of trauma, operation, ketoacidosis, hypoglycemia leaded to unconsciousness in last 4 weeks or using medication except insulin were not included into the study. Spot urine specimens were tested for gross proteinuria by means of a reagent strip (Labstix, Ames, Miles Inc., Elkhart, IN, USA) and patients with gross proteinuria and abnormal urine sediments were excluded.

Patients were hospitalized to our medical center and they were instructed to collect 24 hour urine specimens without any extra exercise other than instructed. Patients were included into the study if their blood pressure, AER and serum creatinine levels were less than 140/90 mmHg, 200 µg·min-1, 1.4 mg·dL-1, respectively. The study population consisted of 9 patients with AER less than 20 µg·min-1 and 7 patients with AER more than 20 µg·min-1 but less than 200 µg·min-1. Table 1 shows some of the clinical and laboratory characteristics of the patients in which no statistical difference was established between any characteristic. Patients gave written informed consent to the study, which was approved by Ethics Committee of Uludag University.

Urine sampling and analysis

Patients were asked to perform 4 periods with different physical activity intensities. Exercise intensities were aimed to be in accordance with daily activities which were validated with pedometer. In the first period (Mild I), they stepped between 1000-5000 in 4 hours (08:00-12:00). In the second period (Moderate) they were asked to walk more than 10 000 steps in 4 hours (13:00-17:00) and to be on upright position. In the third period (Mild II) they were again asked to walk approximately 1000-5000 steps in 4 hours (18:00-22:00) and in the fourth period (Resting ) they were requested to lay down as much as possible and to have step count less than 500 (23:00-08:00). Timed urine samples were collected separately by 1 hour further at the end each period. Blood glucose levels were checked in every hour during the third period and at 3 hour intervals during rest of the day to exclude hypoglycemia and striking hyperglycemia.

Urinary albumin and creatinine excretion rates of urine samples were determined. Timed urinary AER ( µg·min-1) and ACR (µg·mg-1) of each period were calculated with the contribution of albuminuria, creatininuria and urine volumes. Urinary albumin level was measured using a competitive immunoassay (Immulite®, DPC, Los Angeles, CA, USA) with interassay and intra-assay variations of 4.4% and 6.7% respectively. Urinary creatinine concentration was analyzed by the Jaffe reaction. Automated biochemical analysis was used for the other determinations in plasma.

Statistical analysis

The albumin concentration measured in the timed urine samples were compared with the albumin concentration quantified from 24-h urine sample of the previous day. AER less than 20 µg·min-1 in the 24-h urine sample was considered as normoalbuminuria. Relationships between 24-h urine samples and timed urine specimens were sought by Pearson correlation. Cut-off values of ACR and AER in timed urine samples were calculated by insertion of 95% confidence intervals to the mean levels of patients with normoalbuminuria quantified from 24-h urine sample. Diagnostic performance was expressed in terms of specificity, sensitivity, positive and negative predictive value. Data are given as mean and standard deviation (SD). Statistical analyses were performed with SPSS 10.0 / PC (SPSS Inc., Chicago, IL), and statistical measures were calculated in the standard manner.

RESULTS

All patients completed the exercising periods within the target step levels. There were no major adverse events during this study. Any patient did not have any symptoms resembling hypoglycemia. Patients blood glucose levels were ranged between 72-282 mg·dL-1. Patients with blood glucose levels higher than 200 mg·dL-1 were checked for ketonuria which nobody presented.

Pearson’s correlations between 24-h urinary AER and urinary ACR are shown in Figure 1. Scatter plot diagrams depict the significant relationship between 24-h urinary AER and urinary ACR during all the periods. In according to calculate the diagnostic performance of ACR, mean range with %95 confidence interval was used as the cut point. The mean level of ACR in 9 patients with normoalbuminuria was 17 µg·mg-1 with a 95% confidence interval 9 µg·mg-1. Twenty six µg·mg-1 (17 µg·mg-1 + 9 µg·mg-1) was accepted as the cut point for detecting normoalbuminuria for using ACR in spot urine samples. According to this cut off value of ACR, diagnostic performance was compared against microalbuminuria results detected by 24-h urine samples (Table 2). Most predictive results were obtained during resting and mild physical activity periods.

Similar calculations were done for urinary AER determined in timed urine specimens during different periods (Figure 2). In patients without microalbuminuria cut point for urinary AER in timed urinary specimens was found as 15 µg·min-1 (12 µg·min-1 + 3 µg·min-1) and diagnostic performance of the AER for this cut-off value during different periods were calculated (Table 3). Diagnostic performance of urinary AER determined in timed urinary specimens showed very similar percentages with ACR. When effect of intensity of exercise on AER considered, resting and mild physical activity seem to be the most accurate.

DISCUSSION

Early detection of microalbuminuria through screening allows interventions aimed at preventing diabetic nephropathy (Mogensen and Chritensen, 1984; Borch-Johnsen et al., 1993). Pathologic microalbuminuria was assumed when the albumin concentration exceeded 20 µ·min-1 in a 24-h urine sample. Because collection of 24-h urine is cumbersome for the patients, many authors claimed that spot urine samples can give reliable results for detecting microalbuminuria. The best method to diagnose microalbuminuria in a spot urine sample is still a matter of discussion. Qualitative measurement of albuminuria in a spot urine sample can give very high levels of false positive/negative results depending on the volume of urine excreted that can be highly variable depending mainly on the individual’s fluid intake and physical activity (Mckenna et al., 1991; Carella et al., 1994; Newman et al., 2000). Proteinuria detected by using dipstick urinalysis despite correlates well with radioimmunassay measurement also documented many false positive values and necessitate repeated testing (Pegoraro et al., 1997). Our results also showed low levels of sensitivity and specificity when quantitative measurement of albuminuria in the urine samples compared with 24-h urine microalbuminuria measurements (data not shown). Timed urine collections, ACR in spot urine and early morning urine are other alternative specimens for the measurement of albumin excretion.

Our results demonstrated a strong correlation between AER in the timed urine specimens and 24-h urinary AER. We aimed to detect the best cut-off value of timed urine sample for the limit of microalbuminuria. In patients without microalbuminuria the cut-off value was calculated as 15 µg·min-1 for timed urine specimens. So, it is assumed that in a timed urine sample albumin excretion less than 15 µg·min-1 shows normoalbuminuria with 95% confidence. Sensitivity and specificity rates of AER level < 15 µg·min-1 in a timed urine specimen for detecting normoalbuminuria were found 71% and 82% respectively.

Our foremost aim was to identify the best time for collecting spot urine sample in detecting microalbuminuria correctly. When diagnostic performance tests were made for the timed urine samples by considering 15 µg·min-1 as the cut-off value, it was found that increased physical activity leaded to low percentage of sensitivity and specificity. For this cut-off value sensitivity and specificity values during the resting period were 88% and 100% respectively, but in moderatively active period these rates were 57% and 67% respectively. So it was concluded that for the detection of urinary albumin excretion accurately in a timed urine sample, inactivity is important.

In the resting period patients were instructed to be inactive as much as they could. Sensitivity and specificity rates of the third period with mild physical activity were very close to the resting period. Since the third period activity (Mild II) was similar with the first period (Mild I), it is obvious that physical activity is not the only cause in the variation of urinary albumin excretion. Blood pressure, sodium intake, protein intake, hyperglycemia could be factors for low sensitivity and specificity of the daytime urine samples.

Timed collections are too cumbersome for the patients and comprise potency for erroneousness during the collection of the timed urine sample. In clinical practice it is very difficult to verify that a timed collection of urine is complete, so urinary albumin measurement in timed urine sample leads to considerable percentage of falsely positive/negative results. Spot urine samples which can easily be acquired in the ambulatory setting has many advantages. To evaluate the diagnostic performance of the albumin excretion in a spot urine sample, we calculated ACR for every period urine samples and compared with the results of urinary albumin excretion results of the 24-h urine samples.

Correlation between albumin/creatinine ratio and urinary albumin excretion of 24-h urine sample was very significant. To find the best cut-off value for results of albumin/creatinine ratio mean levels and 95% confidence intervals were evaluated. In patients without microalbuminuria calculated cut-off value was 26 µg·mg-1 and this level was evaluated for the significance of diagnostic performance for different periods. Sensitivity and specificity rates of ACR level < 26 µg·mg-1 for detecting normoalbuminuria were 80% and 79%, respectively. When diagnostic performance tests were performed for each period, best results were obtained during resting period with sensitivity rate of 86% and specificity rate of 89%.

Conclusions

In conclusion although spot urine samples give false positive and negative results, timed urine samples can predict microalbuminuria with a very high accurate percentage if samples collected without erroneously. Our data did not provide any advantage of ACR compared with albuminuria measured in timed urine sample. For timed urine samples albumin excretion less than 15 µg·min-1 is highly predictive for normoalbuminuria. In conditions of uncertainty about collection of timed urine sample, albumin creatinine ratio can be used with great confidence. In this condition, albumin creatinine ratio lower than 26 µg·mg-1 is well predictive for normoalbuminuria. With increasing physical activity during urine collection diagnostic performances of the cut-off values go downhill. For detecting microalbuminuria best results are reached with the early-morning urine samples.

AUTHOR BIOGRAPHY
     
 
Ercan Tuncel
 
Employment:Assoc. Prof. Department of Endocrinology, Medical Faculty, Uludag University
 
Degree: MD
 
Research interests: Diabetic complications, obesity, dyslipidemia
  E-mail: ercant@uludag.edu.tr
   
   

     
 
Erdinc Erturk
 
Employment:Assoc. Prof. Department of Endocrinology, Medical Faculty, Uludag University
 
Degree: MD
 
Research interests: Secondary diabetes, diabetic complications, adrenal disorders
  E-mail: ererturk@uludag.edu.tr
   
   

     
 
Canan Ersoy
 
Employment:Ass. Prof. Department of Endocrinology, Medical Faculty, Uludag University
 
Degree: MD
 
Research interests: Diabetic complications, obesity, dyslipidemia.
  E-mail: cersoy@uludag.edu.tr
   
   

     
 
Sinem Kiyici
 
Employment:Physician, Department of Endocrinology, Medical Faculty, Uludag University
 
Degree: MD
 
Research interests: Diabetic complications, obesity, dyslipidemia
  E-mail:
   
   

     
 
Cevdet Duran
 
Employment:Physician, Department of Endocrinology, Medical Faculty, Uludag University
 
Degree: MD
 
Research interests: Diabetic complications, obesity, dyslipidemia
  E-mail:
   
   

     
 
Nesrin Kuru
 
Employment:Physician, Doruk Medical Center
 
Degree: MD
 
Research interests: Diabetes Mellitus
  E-mail:
   
   

     
 
Sazi Imamoglu
 
Employment:Medical Director, Prof., Department of Endocrinology, Medical Faculty, Uludag University
 
Degree: MD
 
Research interests: Diabetes treatment, diabetic complications.
  E-mail:
   
   

REFERENCES
Abbott K.C., Sanders L.R., Bakris G.L. (1994) Microalbuminuria in non-insulin-dependent diabetes mellitus. Implications for renal survival. Archieves of Internal Medicine 154, 146-153.
Agewall S., Wikstrand J., Ljungman S., nd Fagerberg B. (1997) Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Risk Factor Intervention Study Group. American Journal of Cardiology 80, 164-169.
Bennett P.H., Haffner S., Kasiske B.L., Keane W.F., Mogensen C.E., Parving H.H., Steffes M.W., Striker G.E. (1995) Screening and management of microalbuminuria in patients with diabetes mellitus: Recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation. American Journal of Kidney Disease 25, 107-112.
Borch-Johnsen K., Wenzel H., Viberti G.C., Mogensen C.E. (1993) Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes?. British Medical Journal 306, 1722-1725.
Carella M.J., Gossain V.V., Rovner D.R. (1994) Early diabetic nephropathy. Emerging treatment options. Archieves of Internal Medicine 154, 625-630.
Derhaschnig U., Kittler H., Woisetschlager C., Bur A., Herkner H., Hirschl M.M. (2002) Microalbumin measurement alone or calculation of the albumin/ creatinine ratio for the screening of hypertension patients?. Nephrology Dialysis and Transplantation 17, 81-85.
Eshoj O., Feldt-Rasmussen B., Larsen M.L., Mogensen E.F. (1987) Comparison of overnight, morning and 24-hour urine collections in the assessmentof diabetic microalbuminuria. Diabetic Medicine 4, 531-533.
Gatling W., Knight C., Hill R.D. (1985) Screening for early diabetic nephropathy: which sample to detect microalbuminuria?. Diabetic Medicine 2, 451-455.
Gomes M.B., Goncalves M.F. (2001) Is there a physiological variability for albumin excretion rate? Study in patients with diabetes type 1 and non-diabetic individuals. Clinical Chemistry Acta 304, 117-123.
Jefferson I.G., Greene S.A., Smith M.A., Smith R.F., Griffin N.K., Baum J.D. (1985) Urine albumin to creatinine ratio-response to exercise in diabetes. Archieves of Disease in Childhood 60, 305-310.
Khawali C., Andriolo A., Ferreira S.R. (2002) Comparison of methods for urinary albumin determination in patients with type 1 diabetes. Brazilian Journal of Medical and Biological Research 35, 337-343.
Krolewski A.S., Warram J.H., Christlieb A.R., Busick E.J., Kahn C.R. (1985) The changing natural history of nephropathy in type I diabetes. American Journal of Medicine 78, 785-794.
Marshall S.M. (1991) Screening for microalbuminuria: Which measurement?. Diabetic Medicine 8, 706-711.
McKenna M.J., Arias C., Feldkamp C.S., Whitehouse F.W. (1991) Microalbuminuria in clinical practice. Archieves of Internal Medicine 151, 1745-1747.
Microalbuminuria Collaborative Study Group (MCSG, United Kingdom) (1993) Risk factors for development of microalbuminuria in insulin dependent diabetic patients: A cohort study. British Medical Journal 306, 1235-1239.
Mogensen C.E., Christensen C.K. (1984) Predicting diabetic nephropathy in insulin-dependent patients. New England Journal of Medicine 311, 89-93.
Mogensen C.E., Keane W.F., Bennett P.H., Jerums G., Parving H.H., Passa P., Steffes M.W., Striker G.E., Viberti G.C. (1995) Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 346, 1080-1084.
Newman D.J., Pugia M.J., Lott C.A., Wallace J.F., Hiar A.M. (2000) Urinary protein and albumin excretion corrected by creatinine and specific gravity. International Journal of Clinical Chemistry and Applied Molecular Biology 294, 139-155.
Pegoraro A., Singh A., Bakir A.A., Arruda J.A., Dunea G. (1997) Simplified screening for microalbuminuria. Annals of Internal Medicine 127, 817-819.
Rowe D.J., Hayward M., Bagga H., Betts P. (1984) Effect of glycaemic control and duration of disease on overnight albumin excretion in diabetic children. British Medical Journal (Clinical Research Edition) 289, 957-959.
Shield J.P., Hunt L.P., Baum J.D., Pennock C.A. (1995) Screening for diabetic microalbuminuria in routine clinical care: Which method?. Archieves of Disease in Childhood 72, 524-525.
Tobe S.W., McFarlane P.A., Naimark D.M. (2002) Microalbuminuria in diabetes mellitus. Canadian Medical Association Journal 167, 499-503.
Viberti G.C., Hill R.D., Jarrett R.J., Argyropoulos A., Mahmud U., Keen H. (1982) Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1, 1430-1432.
Yudkin J.S., Forrest R.D., Jackson C.A. (1988) Microalbuminuria is a predictor of vascular disease in non-diabetic subjects: Islington Diabetes Survey. Lancet 2, 530-533.








Back
|
PDF
|
Share